Clinton Matson

Clinton Matson, Ph.D., is a Principal Scientist II at Gilead Sciences with over 9 years of experience in small molecule drug development, focusing on tumor intrinsic oncology targets for solid and hematologic cancers. Previously, Clinton served as a postdoctoral research fellow at the University of Minnesota and the Fred Hutchinson Cancer Research Center, where significant contributions included the development of novel xeno- models of human prostate cancer and mentoring students. Clinton earned a Ph.D. in Molecular, Cellular, Developmental Biology, and Genetics from the University of Minnesota-Twin Cities and a B.S. in Cell/Cellular and Molecular Biology from the University of Washington.